Literature DB >> 15516191

Impact of hepatitis A vaccination of Indigenous children on notifications of hepatitis A in north Queensland.

Jeffrey N Hanna1, Susan L Hills, Jan L Humphreys.   

Abstract

OBJECTIVE: To describe the impact of a hepatitis A vaccination program for Indigenous children in north Queensland.
DESIGN: Enhanced surveillance of all notified cases of hepatitis A in north Queensland from 1996 to 2003.
SETTING: North Queensland; population, 596 500 people, including about 6900 Indigenous children aged under five years.
INTERVENTIONS: Hepatitis A vaccine was provided to Indigenous children in north Queensland from February 1999; two doses were recommended (at 18 months and 2 years of age), as was catch-up vaccination up to the sixth birthday.
RESULTS: In the 4 years 1996-1999, 787 cases of hepatitis A were notified in north Queensland, 237 (30%) of which were in Indigenous people. The average annual notification rates in Indigenous and non-Indigenous people during this period were 110 and 25 cases per 100 000 persons, respectively. In the first 4 years after introduction of the vaccination program (2000-2003), 66 cases of hepatitis A were notified. Only nine of the 66 (14%) were in Indigenous people. The average annual notification rates in Indigenous and non-Indigenous people in 2000-2003 were 4 and 2.5 cases per 100 000 persons, respectively.
CONCLUSION: Hepatitis A seems to have been eradicated from Indigenous communities in north Queensland very soon after the vaccination program began. The rapid decline in notifications in non-Indigenous as well as Indigenous people suggests the program quickly interrupted chains of transmission from Indigenous children to the broader community. To our knowledge this is the first evidence that a hepatitis A vaccination program targeting a high-risk population within a community can reduce disease in the broader community. Hepatitis A vaccine should be provided to other high-risk Indigenous children elsewhere in Australia.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15516191     DOI: 10.5694/j.1326-5377.2004.tb06404.x

Source DB:  PubMed          Journal:  Med J Aust        ISSN: 0025-729X            Impact factor:   7.738


  9 in total

Review 1.  Vaccination greatly reduces disease, disability, death and inequity worldwide.

Authors:  F E Andre; R Booy; H L Bock; J Clemens; S K Datta; T J John; B W Lee; S Lolekha; H Peltola; T A Ruff; M Santosham; H J Schmitt
Journal:  Bull World Health Organ       Date:  2008-02       Impact factor: 9.408

Review 2.  Immunization against Hepatitis A.

Authors:  Daniel Shouval
Journal:  Cold Spring Harb Perspect Med       Date:  2019-02-01       Impact factor: 6.915

3.  Usage of an online tool to help policymakers better engage with research: Web CIPHER.

Authors:  Steve R Makkar; Frances Gilham; Anna Williamson; Kellie Bisset
Journal:  Implement Sci       Date:  2015-04-23       Impact factor: 7.327

4.  Using conjoint analysis to develop a system to score research engagement actions by health decision makers.

Authors:  Steve R Makkar; Anna Williamson; Tari Turner; Sally Redman; Jordan Louviere
Journal:  Health Res Policy Syst       Date:  2015-04-26

Review 5.  Hepatitis A vaccination and its immunological and epidemiological long-term effects - a review of the evidence.

Authors:  Christian Herzog; Koen Van Herck; Pierre Van Damme
Journal:  Hum Vaccin Immunother       Date:  2020-12-16       Impact factor: 3.452

6.  Estimating the critical immunity threshold for preventing hepatitis A outbreaks in men who have sex with men.

Authors:  D G Regan; J G Wood; C Benevent; H Ali; L Watchirs Smith; P W Robertson; M J Ferson; C K Fairley; B Donovan; M G Law
Journal:  Epidemiol Infect       Date:  2015-11-13       Impact factor: 4.434

7.  Using conjoint analysis to develop a system of scoring policymakers' use of research in policy and program development.

Authors:  Steve R Makkar; Anna Williamson; Tari Turner; Sally Redman; Jordan Louviere
Journal:  Health Res Policy Syst       Date:  2015-08-04

Review 8.  Hepatitis Vaccines.

Authors:  Sina Ogholikhan; Kathleen B Schwarz
Journal:  Vaccines (Basel)       Date:  2016-03-11

9.  High prevalence of hepatitis A in indigenous population in north Brazil.

Authors:  Vanessa Salete de Paula; Flavio Augusto Pádua Milagres; Guilherme de Macêdo Oliveira; Juliana Custódio Miguel; Helena Medina Cruz; Leticia de Paula Scalioni; Vanessa Alves Marques; Monica de Avelar Figueiredo Mafra Magalhães; Anselmo Rocha Romão; Renata Gracie; Livia Melo Villar
Journal:  BMC Res Notes       Date:  2020-09-29
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.